Instantaneous wave-free ratio (iFR®) to determine hemodynamically significant coronary stenosis: A comprehensive review

doi:10.4330/wjc.v10.i12.267

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12214)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

605

WORD

289

HTML

7436

Figures (1-3)

514

Tables (1-1)

277

Sum=9121

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

425

Download

738

Sum=1163

Publishing Process of This Article

Item

Count

Browse

866

Download

1064

Sum=1930

Dec 26, 2018 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Cardiol. Dec 26, 2018; 10(12): 267-277
Published online Dec 26, 2018. doi: 10.4330/wjc.v10.i12.267

Table 1 Significant instantaneous wave-free ratio-(iFR^®)-studies

	Advise	Verify	Clarify	*Park et al[39]*	Resolve	Advise in practice	*Indolfi et al[42]*	ADVISE II	*Harle et al[44]*	*Van de Hoef et al[45]*	DEFINE-FLAIR	iFR^®-SWEDHEART
First author journal and year of Publication	Sen et al[18]. J Am Coll Cardiol 2012	Berry et al[37]. J Am Coll Cardiol 2013	Sen et al[38]. J Am Coll Cardiol 2013	Park et al[39]. Int J Cardiol 2013	Jeremias et al[40]. J Am Coll Cardiol 2014	Petraco et al[41]. Am Heart J 2014	Indolfi et al[42]. Int J Cardiol 2015	Escaned et al[43]. J Am Coll Cardiol-Intv 2015	Harle et al[44]. Int J Cardiol 2015	Van de Hoef et al[45]. Euro-Intervention 2015	Davies et al[19]. N Engl J Med 2017	Götberg et al[20]. N Engl J Med 2017
Study design	PC, multicenter, non-randomized	PC, multicenter, non-randomized	PC, multicenter	PC, multicenter, non-randomized	RS, multicenter, non-randomized	PC, multicenter, non-randomized	PC, monocenter, non-randomized	PC, multicenter, non-randomized	PC, monocenter, non-randomized	PC, multicenter, non-randomized	PC, multicenter, randomized	PC, multicenter, randomized
Countries (centers)	2 (3)	6 (6)	2 (3)	1 (2)	7 (15)	101 (16)	1 (1)	8 (45)	1 (1)	3 (7)	19 (49)	3 (14)
Included patients	131	206	51	238	1768	313	82	598	109	228 (iFR^® = 66)	2492 (iFR^® = 1242)	2037 (iFR^® = 1019
Stenoses	157	206	51	238	1974	392	123	690	151	299 (iFR^® = 85)	3183 (iFR^® = 1575)	3004 (iFR^® = 1568)
Hemodynamic relevant stenoses (%)	N/A	134 (65)	N/A	103 (43.3)	N/A	153 (39)	37 (30.1)	248 (35.9)	N/A	N/A	451 (28.6)	457 (29.1)
Age in years ± SD	62.6 ± 10.2	65.2 ± 10.2	66.2 ± 9.2	62.8 ± 0.6	63.4 ± 10.3	67 ± 11	64 ± 9	63.6 ± 10.8	67 ± 11	58 ± 11	65.5 ± 10.8	67.6 ± 9.6
Men (%)	83.5	71	82.4	68	74.9	79	81.7	68.9	63.9	68	77.5	74.2
Diabetes mellitus (%)	54 (34.4)	50 (24)	14 (27.4)	66 (28)	497 (28.1)	94 (30)	14 (17.1)	209 (35)	N/A	10 (15)	382 (30.8)	232 (22.8)
Hypertonia (%)	88 (56.1)	137 (67)	18 (35.2)	133 (56)	N/A	232 (74)	61 (74.4)	471 (78.8)	N/A	25 (38)	873 (70.3)	730 (71.6)
Smoking (%)	34 (21.7)	64 (31)	15 (29.4)	64 (27)	520 (29.4)	160 (51)	49 (59.8)	135 (22.6)	N/A	21 (32)	243 (19.6)	159 (15.6)
One-vessel CAD (%)	108 (68.8)	85 (41)	N/A	N/A	N/A	113 (36)	50 (61)	N/A	75 (69.4)	N/A	N/A	452 (44.3)
Multi-vessel CAD (%)	49 (31.2)	105 (51)	N/A	N/A	951 (53.8)	197 (63)	32 (39)	N/A	33 (30.6)	N/A	505 (40.7)	364 (35.7)
Stable angina (%)	151 (96.2)	140 (68)	N/A	151 (63)	1216 (68.6)	228 (73)	29 (35)	320 (53.5)	N/A	N/A	986 (79.4)	632 (62.0)
Unstable angina (%)	6 (3.8)	46 (22)	N/A	84 (36)	255 (14.4)	85 (27)	53 (65)	151 (25.3)	N/A	N/A	186 (15.0)	211 (20.7)
iFR^® cut-off	0.83	≤ 0.83	0.86	0.9	0.9	0.9	0.92	0.89	0.896	0.9	0.89	0.89
MACE-rate after 1 yr (iFR^®vs FFR, P-value)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	6.8 vs 7.0 (P = 0.003)	6.7 vs 6.1 (P = 0.007)
Adverse events (iFR^®vs FFR, P-value)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	3.1 vs 30.8 (P < 0.001)	3.0 vs 68.3 (P < 0.0001)
Diagnostic accuracy in % (iFR^®vs FFR)	93	68	92.3	82	80.4	80	81.3	82.5	83.4	N/A	N/A	N/A

PC: Prospective cohort study; RS: Retrospective study; FFR: Fractional flow reserve; N/A: Not available; MACE: Major adverse cardiac events.

Citation: Baumann S, Chandra L, Skarga E, Renker M, Borggrefe M, Akin I, Lossnitzer D. Instantaneous wave-free ratio (iFR^®) to determine hemodynamically significant coronary stenosis: A comprehensive review. World J Cardiol 2018; 10(12): 267-277
URL: https://www.wjgnet.com/1949-8462/full/v10/i12/267.htm
DOI: https://dx.doi.org/10.4330/wjc.v10.i12.267